Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TopBuild (BLD) Asset Writedowns and Impairment: 2015-2025

Historic Asset Writedowns and Impairment for TopBuild (BLD) over the last 11 years, with Sep 2025 value amounting to $4.1 million.

  • TopBuild's Asset Writedowns and Impairment rose 7.18% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 15.20%. This contributed to the annual value of $15.7 million for FY2024, which is 142.89% up from last year.
  • According to the latest figures from Q3 2025, TopBuild's Asset Writedowns and Impairment is $4.1 million, which was up 435.47% from -$1.2 million recorded in Q2 2025.
  • Over the past 5 years, TopBuild's Asset Writedowns and Impairment peaked at $9.9 million during Q1 2025, and registered a low of -$2.2 million during Q4 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $3.3 million (2023), whereas its average is $3.2 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first slumped by 204.26% in 2022, then spiked by 323.80% in 2024.
  • TopBuild's Asset Writedowns and Impairment (Quarterly) stood at $2.1 million in 2021, then crashed by 204.26% to -$2.2 million in 2022, then surged by 58.72% to -$899,000 in 2023, then soared by 323.80% to $2.0 million in 2024, then grew by 7.18% to $4.1 million in 2025.
  • Its Asset Writedowns and Impairment was $4.1 million in Q3 2025, compared to -$1.2 million in Q2 2025 and $9.9 million in Q1 2025.